Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients von BASARA, N, BLAU, W. I, RÖMER, E, RUDOLPHI, M, BISCHOFF, M, KIRSTEN, D, SANCHEZ, H, GÜNZELMANN, S, FAUSER, A. A

Volltext

Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients von Basara, N, Blau, WI, Kiehl, MG, Schmetzer, B, Bischoff, M, Kirsten, D, Günzelmann, S, Fauser, AA

Volltext

Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation von Rieger, Kathrin, Marinets, Olga, Fietz, Thomas, Körper, Sixten, Sommer, Dagmar, Mücke, Carola, Reufi, Birgit, Blau, Wolfgang I., Thiel, Eckhard, Knauf, Wolfgang U.

Volltext

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient von Basara, N, Blau, W.I, Kiehl, M.G, Römer, E, Rudolphi, M, Bischoff, M, Kirsten, D, Sanchez, H, Günzelmann, S, Fauser, A.A

Volltext

New strategies in GVHD prophylaxis von Kiehl, M G, Shipkova, M, Basara, N, Blau, W I, Fauser, A A

Volltext

Peripheral blood stem cell (PBSC) transplantation vs. bone marrow from unrelated donors von Ringden, O, Remberger, M, Runde, V, Bornhauser, M, Blau, WI, Holig, K, Basara, N, Beelen, DW, Hagglund, H, Basu, O, Ehninger, G, Fauser, AA

Volltext